Stellate Ganglion Block for COVID-19-Induced Olfactory Dysfunction
NCT05445921
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Anosmia
Hyposmia
Parosmia
Olfactory Disorder
Interventions
DRUG:
Stellate Ganglion Block
Sponsor
Washington University School of Medicine